EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Smart Mesoporous Silica Nanoparticle-Based Drug Delivery Systems: Recent Advances in Biomedical Applications, Wound Healing and Therapeutic Perspectives

Manickam Rajkumar iD, Nadarajan Prathap, Vivekanand Ankush Kashid iD, Bhupendra G Prajapati iD, Kokila Palani, Parappurath Narayanan Sudha, Prabhakaran Rajkumar iD, Biswajit Basu

Pharmaceutics · 21.08.2026 · 18 (8) · 1044

DOI: 10.3390/pharmaceutics18081044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 21.08.2026. Verfasst von Manickam Rajkumar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Karpagam Academy of Higher Education (Deemed to be University), Coimbatore 641 021, Tamil Nadu, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesoporous silica nanoparticles (MSNs) have emerged as versatile nanocarriers for biomedical applications because of their unique physicochemical properties, including high surface area, large pore volume, excellent drug-loading capacity, controllable biodegradation, and facile surface functionalization. These characteristics have enabled the development of advanced drug delivery systems with enhanced therapeutic efficacy, targeted delivery, improved bioavailability, and reduced systemic toxicity. Recent advances in MSN synthesis, physicochemical properties, surface engineering, and functionalization strategies have significantly improved their biological performance and therapeutic potential. In particular, integrating polymers, lipids, and liposomes with MSN platforms has enhanced colloidal stability, circulation time, cellular uptake, and target specificity, thereby facilitating efficient, stimuli-responsive drug delivery. This review highlights MSN-based drug delivery systems in cancer therapy, where multifunctional nanocarriers enable site-specific delivery, controlled drug release, enhanced tumor accumulation, and reduced off-target effects. The review discusses the expanding roles of MSNs in antimicrobial therapy, wound healing, tissue engineering, and regenerative medicine, emphasizing their ability to promote localized therapeutic delivery, immunomodulation, angiogenesis, and tissue regeneration. The review discusses the diagnostic and theragnostic capabilities of MSNs for disease imaging and monitoring. It also critically evaluates current challenges related to biocompatibility, biodegradation, toxicity, biological barriers, large-scale manufacturing, clinical translation, and regulatory considerations. This review provides a comprehensive overview of recent progress, current limitations, and future opportunities for MSN-based platforms in targeted drug delivery and advanced biomedical applications, supporting their continued advancement toward clinical translation and precision medicine.

Schlagwörter

Stichwörter der Autor:innen

drug delivery systemsmesoporous silica nanoparticlesstimuli-responsive nanocarrierstissue engineeringwound healing

Autor:innen und Institutionen

  • Department of Biotechnology, Karpagam Academy of Higher Education (Deemed to be University), Coimbatore 641 021, Tamil Nadu, India.
  • Center for Cancer Research, Karpagam Academy of Higher Education (Deemed to be University), Coimbatore 641 021, Tamil Nadu, India.
  • Department of Science and Technical Development, Manash Kozybayev North Kazakhstan University, Petropavlovsk 150000, Kazakhstan.
  • MABD Institute of Pharmaceutical Education and Research, Babhulgaon, Yeola, Nashik 423 401, Maharashtra, India.
  • Center for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura 140 401, Punjab, India.
  • Department of Pharmaceutics, Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara 391 760, Gujarat, India.

ORCID-Profile: Manickam Rajkumar, Vivekanand Ankush Kashid, Bhupendra G Prajapati, Prabhakaran Rajkumar

Zitieren

APA

Rajkumar, M., Prathap, N., Kashid, V. A., Prajapati, B. G., Palani, K., Sudha, P. N., Rajkumar, P., & Basu, B. (2026). Smart Mesoporous Silica Nanoparticle-Based Drug Delivery Systems: Recent Advances in Biomedical Applications, Wound Healing and Therapeutic Perspectives. Pharmaceutics, 18(8), 1044. https://doi.org/10.3390/pharmaceutics18081044

Vancouver

Rajkumar M, Prathap N, Kashid VA, Prajapati BG, Palani K, Sudha PN, et al. Smart Mesoporous Silica Nanoparticle-Based Drug Delivery Systems: Recent Advances in Biomedical Applications, Wound Healing and Therapeutic Perspectives. Pharmaceutics. 2026;18(8):1044. doi:10.3390/pharmaceutics18081044

BibTeX
@article{Rajkumar2026,
  author = {Rajkumar, Manickam and Prathap, Nadarajan and Kashid, Vivekanand Ankush and Prajapati, Bhupendra G and Palani, Kokila and Sudha, Parappurath Narayanan and Rajkumar, Prabhakaran and Basu, Biswajit},
  title = {Smart Mesoporous Silica Nanoparticle-Based Drug Delivery Systems: Recent Advances in Biomedical Applications, Wound Healing and Therapeutic Perspectives},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {8},
  pages = {1044},
  doi = {10.3390/pharmaceutics18081044}
}
Kostenlos starten →